The PE Ratio as of December 2025 (TTM) for Serina Therapeutics, Inc. (SER) is -1.86

According to Serina Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.86. This represents a change of -725.07% compared to the average of 0.30 of the last 4 quarters.

Serina Therapeutics, Inc. (SER) Historical PE Ratio (quarterly & annually)

How has SER PE Ratio performed in the past?

The mean historical PE Ratio of Serina Therapeutics, Inc. over the last ten years is -7.66. The current -1.86 PE Ratio has changed 2.33% with respect to the historical average. Over the past ten years (40 quarters), SER's PE Ratio was at its highest in in the September 2024 quarter at 10.50. The PE Ratio was at its lowest in in the March 2018 quarter at -104.90.

Serina Therapeutics, Inc. (SER) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Serina Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Serina Therapeutics, Inc. (SER) Average PE Ratio

How has SER PE Ratio performed in the past?

The current PE Ratio of Serina Therapeutics, Inc. (SER) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Serina Therapeutics, Inc. (SER) PE Ratio vs. Peers

How is SER’s PE Ratio compared to its peers?

Serina Therapeutics, Inc.’s PE Ratio is greater than Genenta Science S.p.A. (-3.44), less than Skye Bioscience, Inc. (-1.13), greater than Jupiter Neurosciences, Inc. (-5.47), less than Aligos Therapeutics, Inc. (-1.21), less than Barinthus Biotherapeutics plc (-0.39), less than INmune Bio, Inc. (-1.00), less than X4 Pharmaceuticals, Inc. (-0.28), greater than Telomir Pharmaceuticals, Inc. Common Stock (-3.75), greater than Grace Therapeutics, Inc. (-6.68), less than CEL-SCI Corporation (-1.03),

Build a custom stock screener for Serina Therapeutics, Inc. (SER) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Serina Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Serina Therapeutics, Inc. (SER) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Serina Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.